12 research outputs found

    Dissecting the gene dose-effects of the APOE Īµ4 and Īµ2 alleles on hippocampal volumes in aging and Alzheimer's disease.

    Get PDF
    To investigate whether there is a specific dose-dependent effect of the Apolipoprotein E (APOE) Īµ4 and Īµ2 alleles on hippocampal volume, across the cognitive spectrum, from normal aging to Alzheimer's Disease (AD).We analyzed MR and genetic data on 662 patients from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database-198 cognitively normal controls (CN), 321 mild-cognitive impairment (MCI) subjects, and 143 AD subjects-looking for dose-dependent effects of the Īµ4 and Īµ2 alleles on hippocampal volumes. Volumes were measured using a fully-automated algorithm applied to high resolution T1-weighted MR images. Statistical analysis consisted of a multivariate regression with repeated-measures model.There was a dose-dependent effect of the Īµ4 allele on hippocampal volume in AD (p = 0.04) and MCI (p = 0.02)-in both cases, each allele accounted for loss of >150 mm(3) (approximately 4%) of hippocampal volume below the mean volume for AD and MCI subjects with no such alleles (Cohen's d =ā€Š-0.16 and -0.19 for AD and MCI, respectively). There was also a dose-dependent, main effect of the Īµ2 allele (p<0.0001), suggestive of a moderate protective effect on hippocampal volume-an approximately 20% per allele volume increase as compared to CN with no Īµ2 alleles (Cohen's d = 0.23).Though no effect of Īµ4 was seen in CN subjects, our findings confirm and extend prior data on the opposing effects of the APOE Īµ4 and Īµ2 alleles on hippocampal morphology across the spectrum of cognitive aging

    Freesurfer hippocampal region of interest.

    No full text
    <p>Coronal, sagittal, and axial (1.5T) T1-weighted MR images from the Freesurfer Image Analysis Suite of sample subject ā€œBertā€, with color overlays depicting the extent of the Freesurfer hippocampal region of interest used to derive hippocampal volumes.</p

    Demographics and Cognitive Summary by Īµ2.

    No full text
    <p>All means are reported Ā± 1 standard error. All <b>bolded</b> parameters were significant according to ANOVA, Chi-square analysis, or Fisherā€™s Exact Test as appropriate. CNā€Š=ā€Šcognitively normal, MCIā€Š=ā€Šmild cognitive Impairment, ADā€Š=ā€ŠAlzheimerā€™s Disease, Īµ2ā€Š=ā€ŠAPOE epsilon 2.</p

    Summary of effects for variables on hippocampal volume: <i>APOE</i> dose-dependent model.

    No full text
    <p>nā€Š=ā€Š662.</p><p>Results for model which treats APOE epsilon ā€œXā€ allele effects as dose-dependent effects. APOE effect sizes of each variable are reported in terms of mm<sup>3</sup>/(unit variable), e.g., the effect of ā€œAgeā€ on the outcome variable, hippocampal volume, is āˆ’23.31 mm<sup>3</sup>/year of age. ā€œ:ā€ denotes interaction terms between variables. Reference for the model is an APOE Īµ3/Īµ3 CN individual. Note the lack of a main effect of APOE epsilon 4 (ā€œApoE4ā€) in the model and thus in CN subjects.</p

    Summary of unadjusted hippocampal volumes by <i>APOE</i> Īµ2 allele dose and diagnostic category.

    No full text
    <p>Unadjusted values. ā€œĪµ2 doseā€ā€Š=ā€Šcopy number of APOE Īµ2 allele,</p><p>ā€œSDā€ā€Š=ā€Šstandard deviation, ā€œSEā€ā€Š=ā€Šstandard error of the mean. ā€œMeanā€ units are mm<sup>3</sup>.</p

    Summary of unadjusted hippocampal volumes by <i>APOE</i> Īµ4 allele dose and diagnostic category.

    No full text
    <p>Unadjusted values. ā€œĪµ4 doseā€ā€Š=ā€Šcopy number of APOE Īµ4 allele,</p><p>ā€œSDā€ā€Š=ā€Šstandard deviation, ā€œSEā€ā€Š=ā€Šstandard error of the mean. ā€œMeanā€ units are mm<sup>3</sup>.</p

    Breakdown of subjects by diagnosis and <i>APOE</i> epsilon 4 status.

    No full text
    <p>CNā€Š=ā€Šcognitively normal, MCIā€Š=ā€Šmild cognitive Impairment, ADā€Š=ā€ŠAlzheimerā€™s Disease, Īµ4ā€Š=ā€ŠAPOE epsilon 4.</p

    Demographic and cognitive summary by Īµ4.

    No full text
    <p>All means are reported Ā± 1 standard error. All <b>bolded</b> parameters were significant according to ANOVA, Chi-square analysis, or Fisherā€™s Exact Test as appropriate. CNā€Š=ā€Šcognitively normal, MCIā€Š=ā€Šmild cognitive Impairment, ADā€Š=ā€ŠAlzheimerā€™s Disease, Īµ4ā€Š=ā€ŠAPOE epsilon 4.</p

    Summary of effects for variables on hippocampal volume: <i>APOE</i> nominal model.

    No full text
    <p>nā€Š=ā€Š660; nā€Š=ā€Š2 APOE Īµ2 CN homozygotes excluded. Results for model which treats APOE epsilon ā€œXā€ allele effects as categorical or ā€œcarrier-statusā€ effect. APOE effect sizes of each variable are reported in terms of mm<sup>3</sup>/(unit variable). ā€œAPOEX1ā€ denotes the effect of 1 copy of APOEX, ā€œAPOEX2ā€ denotes the effect of 2 copies of APOEX. Unlike the results of the above model, this model does not have the assumption of dose-dependency.</p><p>ā€œ:ā€ denotes interaction terms between variables. Reference for the model is an APOE Īµ3/Īµ3 CN individual.</p

    Dose-response of hippocampal volumes.

    No full text
    <p>Dose-dependency of hippocampal volume by <i>APOE</i> epsilon 4 allele load in Mild Cognitive Impairment (MCI) and Alzheimer Disease (AD). Each error bar is constructed using Ā±1 standard error of the mean.</p
    corecore